Honest and candid knowledge sharing
|
Hi! When we ask the T2B community to leave feedback for our events, we genuinely read through every comment, scrutinizing the data to see what’s working and what you want us to do more of (or less of!). That’s how we know that one of the traits you value most from our programming is that it promotes raw, honest dialogue and that we get to the heart of whatever topic is at hand quickly and in a real, meaningful way for the community. And that’s precisely what we’ll be doing at our inaugural Biopharma Comms Forum on June 17th during BIO. With candid panels and keynotes, small-group discussions, and of course, time for networking, this event will give you a different kind of opportunity to engage with peers in a way you simply can’t online. (The topline schedule is live on the event website.) Don’t miss your chance to be part of something specialThanks to our generous Host Sponsor, Takeda; Marquee Sponsor, Waterhouse; and Forum Supporter, Fullintel, we’ve ensured that tickets for this inaugural event are free for T2B Pro and Student members. Michelle and I went through the ticket tally yesterday, and we really mean it when we say that tickets are limited. If you’re a Pro or Student member, we highly, highly encourage you to reserve your spot by next Wednesday. We’ve already received requests from Basic members to attend the forum, so once any remaining tickets go on sale (for $475) for T2B Basic members on May 1st, we cannot guarantee Pro/Student members a spot. RSVP for the forum here.
T2B’s pillars for 2025 are strategic learning, knowledge sharing, and building connections. In order for all of those to be effective, we depend on the community’s candor, openness – even vulnerability, and time to invest in yourself… and in the future of our profession. And the T2B Biopharma Comms Forum is the perfect place for this! Lynnea |
T2B Monthly
Hi! The outcomes of the annual American Society of Clinical Oncology (ASCO) meeting will flood the media landscape with clinical updates, milestone announcements, and analyst notes. So biopharma comms pros and storytellers must understand how to stand out during one of healthcare’s most concentrated news moments. Enter the Q2 Media Minds Panel: Oncology Reporting and ASCO Coverage. “Top-Tier Perspective on ASCO and Beyond: How to Stand Out During Concentrated News Moments” is happening...
Hi! Last week, the T2B community tackled the topic of trust. In an intriguing and very candid Comm Convo led by speakers Kris Baum (former FDA, CDER), Mary Kosinski (FleishmanHillard), and Sarah Spencer (Vor Bio), we explored how the relationships we build shape our ability to lead, influence, and respond. With so many specific anecdotes and practical tips shared, it was hard to narrow down to just 10 key takeaways, but we managed it (barely!): Leverage science as your trust anchor. When...
Hi! We’re all about bringing together the most creative minds in biopharma in a bid to secure and enhance the future of our profession. One of the many ways we do this is through our roundtables, which are driven directly by members who specialize in, and are passionate about, key areas of biopharma communications. And the next discipline on that roster is patient advocacy and engagement. Everything you need to know about the Patient Advocacy and Engagement Roundtable This roundtable will...